Prakt. lékáren. 2006; 2(6): 261-264

Možnosti farmakoterapie deprese

prof. MUDr. Eva Češková CSc
Psychiatrická klinika LF MU a FN Brno

Nejprve je krátce shrnuta historie vývoje antidepresiv. Dále je uvedeno jejich dělení, účinnost a snášenlivost. Jsou uvedeny nové technologické postupy. Krátce jsou zmíněny možnosti prolomení farmakorezistence. Pozornost je věnována individuálně volbě antidepresiva.

Keywords: Klíčová slova: antidepresiva, účinnost, snášenlivost, farmakoresistentní deprese, volba antidepresiva.

Published: February 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Češková E. Možnosti farmakoterapie deprese. Pharmacy for Practice. 2006;2(6):261-264.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Češková E, Pálenský V, Skotáková S. Současné možnosti farmakoterapie deprese. Čes a slov Psychiatrie 2004; 100: 148-152.
    2. Češková E. Duálně působící antidepresiva. Čes a slov Psychiatrie 101, 2005; 101: 207-212.
    3. Češková E. Možnosti farmakoterapie deprese. Psychiatr pro praxi, 6, 2005; 6: 233-236.
    4. Češková E. Trazodon v neurologické praxi. Neurologie pro praxi 2006; 7:114-116.
    5. Demyttenaere K. Risk factors and predictors of compliance in depression. Eur Neuropsychopharmacology 13, 2003; 13: 69-75. Go to original source... Go to PubMed...
    6. Dodd S, Horgan D, Malhi GS, Berk M. To combine or not to combine? Literature review of antidepressants combination therapy. J Affect Disord 2005; 89: 1-11. Go to original source... Go to PubMed...
    7. Einarson TR, Einarson A. Newer antidepressants in pregnancy and rates of malformations: a meta-analysis of prospective comparative studies. Pharmacoepidemiol Drug Saf 2005; 14: 823-7. Go to original source... Go to PubMed...
    8. Fava M, Davidson KG. Definition and epidemiology of treatment-resistant depression. Psychiatr Clin North Am 1996; 19: 179-200. Go to original source... Go to PubMed...
    9. Möller H.-J. Therapieresistenz auf Antidepresiva. Der Nervenarzt 2004; 5: 499-517. Go to original source... Go to PubMed...
    10. Rush AJ, Trivedi MH, Wisniewski SR et al. Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. N Engl J Med 2006; 354: 1231-42. Go to original source... Go to PubMed...
    11. Stahl SM. At long last, long-lasting psychiatric medications: an overview of controlled-release technologies. J Clin Psychiatry 2003; 64: 355-356. Go to original source... Go to PubMed...
    12. Stahl SM. Essentials psychopharmacology. 2nd edition. Cambridge University Press, 2000.
    13. Žourková A. Antidepresiva v léčbě sexuálních dysfunkcí u mužů. Psychiat. pro Praxi, 6, 2005; 6: 66-70.

    Return to the content


    Pharmacy for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.